{"disease":{"id":"cognitive-impairment-associated-with-schizophrenia","name":"cognitive impairment associated with schizophrenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05686239","title":"A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Recognify Life Sciences","has_results":false},{"nct_id":"NCT03745820","title":"A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT05136690","title":"Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02855411","title":"A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT07446478","title":"TIS for Improving Cognitive Impairment Associated With Schizophrenia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Central South University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}